Riccardo Canevari
Follow
Get notifications in MyBN when activity occurs.
Riccardo Canevari
Chief Executive Officer, Managing Director / Radiopharm Theranostics
Most Notable Role
Mr Canevari has experience across specialty pharma, oncology and radiopharmaceuticals. He was most recently Chief Commercial Officer of Novartis company Advanced Accelerator Applications, a radiopharmaceutical and nuclear medicine company
Lists and Charts
Total Shareholder Return as at 28/06/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 808th | MEC Resources | 0% | -4% |
| 1358th | AustChina Holdings | -43% | -8% |
| 1606th | Radiopharm Theranostics | -62% | |
| 1870th | Solis Minerals | -93% |
1769 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | AustChina Holdings | -$186k |
| 839th | | Radiopharm Theranostics | $6.2m |
| 1081st | | MEC Resources | $250k |
| 1083rd | | Solis Minerals | $247k |
1333 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
 | NEWS: Tagged in Radiopharm ups stake in US cancer-fighting venture | 26 Aug 2024 |
| NEWS: Tagged in US medical guru jumps into Radiopharm cancer fight | 20 Aug 2024 |
| NEW ROLE: Chief Executive Officer, Managing Director, Radiopharm Theranostics | 07 Aug 2024 |
| NEW ROLE: Chief Executive Officer, Managing Director, Radiopharm Theranostics | 07 Aug 2024 |
